Roche Holding AG (ROG.SW)

CHF 255.0

(-1.09%)

Market Cap (In CHF)

204.46 Billion

Revenue (In CHF)

58.71 Billion

Net Income (In CHF)

11.49 Billion

Avg. Volume

1.22 Million

Currency
CHF
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
212.9-288.2
PE
-
EPS
-
Beta Value
0.145
ISIN
CH0012032048
CUSIP
H69293217
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Dr. Thomas Schinecker
Employee Count
-
Website
https://www.roche.com
Ipo Date
1995-08-03
Details
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.